Amgen Launches Preemptive Strike in Patent Battle
In an effort to fend off future claims of patent infringement relating to two of its anti-arthritis drugs, Amgen Inc. has filed a lawsuit in a federal court in Delaware seeking...To view the full article, register now.
Already a subscriber? Click here to view full article